INCA036873
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCA036873, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies [Phase 1]